These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16335504)

  • 21. [Economic evaluation of health technologies: theory and practice].
    Abadi-Korek I; Shemer J
    Harefuah; 2008 Jun; 147(6):509-11, 574. PubMed ID: 18693627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained and full fetal hemoglobin production after failure of bone marrow transplant in a patient homozygous for beta 0-thalassemia: a clinical remission despite genetic disease and transplant rejection.
    Paciaroni K; Gallucci C; De Angelis G; Alfieri C; Roveda A; Lucarelli G
    Am J Hematol; 2009 Jun; 84(6):372-3. PubMed ID: 19373892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Policy making and roles of health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries.
    Agarwal RK; Sedai A; Dhimal S; Ankita K; Clemente L; Siddique S; Yaqub N; Khalid S; Itrat F; Khan A; Gilani SK; Marwah P; Soni R; Missiry ME; Hussain MH; Uderzo C; Faulkner L
    J Am Med Inform Assoc; 2014; 21(6):1125-8. PubMed ID: 24714444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotechnology and Medicare's new technology policy: lessons from three case studies.
    Keenan PS; Neumann PJ; Phillips KA
    Health Aff (Millwood); 2006; 25(5):1260-9. PubMed ID: 16966721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common queries in thalassemia care.
    Panigrahi I; Marwaha RK
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 29. Largest biotechnology companies.
    Mod Healthc; 2013 Sep; 43(39):34. PubMed ID: 24199305
    [No Abstract]   [Full Text] [Related]  

  • 30. The policy outlook from the Hill.
    Vastag B
    Nat Biotechnol; 2007 Jan; 25(1):13-6. PubMed ID: 17211381
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resource allocation to brain research in Europe (RABRE).
    Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
    Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada.
    Rosenberg-Yunger ZR; Daar AS; Singer PA; Martin DK
    Health Policy; 2008 Sep; 87(3):359-68. PubMed ID: 18358556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thai health technology assessment guideline development.
    Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S11-5. PubMed ID: 19253483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health technology assessment (HTA): definition, role and use in the changing healthcare environment.
    Gallio D; Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():7-11. PubMed ID: 18924460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.